The National Lipid Association's campaign for National Cholesterol Education Month is a social-media focused initiative to raise awareness about the importance of cholesterol management and its impact on cardiovascular health. Throughout September, the NLA will lead a social media campaign and engagement initiative aimed at educating the public, healthcare professionals, and communities beyond NLA membership about the risks of high cholesterol and the benefits of proactive lipid management. This campaign will feature educational content, patient resources, and interactive activities designed to promote regular cholesterol screenings, to encourage lifestyle changes, and highlight the latest research and guidelines in lipid management. The goal is to empower individuals with the knowledge and tools necessary to take control of their cholesterol levels and reduce the risk of heart disease.
Follow our twitter campaign to get in on the action, hear from professionals, and ask your questions!
Explore the abundance of resources shared throughout the month below:
- What’s next for Lipoprotein(a)? Insights from an Expert Discussion Group
- The ABCs of Lipoprotein(a)
- Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
- A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
- Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association
- Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective
- The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases
- Clinical and cost benefits of medical nutrition therapy by registered dietitian nutritionists for management of dyslipidemia: A systematic review and meta-analysis
- An Indian Adapted Mediterranean Diet: A feasibility study
- Circulation Publication: Multisociety Guideline on the Management of Blood Cholesterol
- Wall Street Journal: The Blood Tests That Can Flag Your Hidden Heart Disease Risk
- NLA Statement: A focused update to the 2019 NLA Scientific Statement on Use of Lipoprotein(a) in Clinical Practice
- JCL Article: Real-World Evaluation of Lipid Testing Rate & Treatment Target Attainment Among High-Risk Patients
- Podcast: Genetic Testing in Dyslipidemia with R. Hegele, MD
- Infographic: NLA Scientific Statement on Lp(a)
- JCL Article: A Mechanism-Based Operational Definition and Classification of Hypercholesterolemia
- NLA Statement: Lipid Measurements in the Management of CVD
- NLA Statement: Statin Associated Muscle Symptoms
- NLA Statement: Nutrition Interventions for Youth with Dyslipidemia
- NLA Statement: Nutrition Interventions for Adults with Dyslipidemia
- Podcast: Statin Underuse Persistence with M.K. Cheeley, PharmD
- Infographic: Lipid Measurements in the Management of CVD
- NLA Statement: Dyslipidemia Management in Women of Reproductive Potential
- LipidSpin Article: How to Identify, Treat, and Advocate for Children with Familial Hypercholesterolemia
- JCL Roundtable: Lipidology and Women's Health
- LipidSpin Article: Lipid Management in Pregnancy and Lactation
- LipidSpin Article: Guidance for Transitioning Patients from Pediatric to Adult Lipid Clinics
- JCL Article: Sex‐Related Differences in Premature Cardiovascular Disease in Familial Hypercholesterolemia
- JCL Article: Counseling Couples at Risk of Having a Child with Homozygous Familial Hypercholesterolemia
- Podcast: Women's Cardiovascular Health
- Webpage: Pediatric Lipid Disorders
- LipidSpin Article: Dyslipidemia and ASCVD in Non-White Ethnic, Racial, and Ancestral Groups
- LipidSpin Article: Differences Associated with Disparities in Lipidology
- JCL Article: Lipid Association of India 2023 Update on Cardiovascular Risk Assessment and Lipid Management in Indian Patients
- JCL Article: Race/Ethnicity and Socioeconomic Status Affect the Assessment of Lipoprotein(a) Levels in Clinical Practice
- LipidSpin Edition: Lipid Management in Specific Populations
- LipidSpin Edition: Racial and Ethnic Differences and Disparities in Lipidology
- LipidSpin Edition: Unique Challenges of ASCVD Prevention in Rural America
- JCL Article: Review of Diagnosis and Therapeutics in Management of Familial Chylomicronemia Syndrome (FCS)
- JCL Article: Spotlight on Abetalipoproteinemia and Related Hypobetalipoproteinemia Disorders: A Simplified Nomenclature and Clinical Guidelines.
- JCL Article: Diagnosis, Treatment, and Clinical Outcomes in 43 cases with Cerebrotendinous Xanthomatosis
- Genetic and Rare Disease Center: Hypobetalipoprotienemia
- Abetalipoproteinemia Foundation
This page was last updated: Sep 25, 2025